COMPARATIVE BIOAVAILABILITY OF PROPRANOLOL - TWICE-DAILY VERSUS 4 TIMES-DAILY ADMINISTRATION

被引:9
作者
DVORNIK, D
KRAML, M
DUBUC, J
PATTERSONKREUSCHER, S
MILOSOVICH, G
MULLANE, JF
机构
[1] AYERST RES LABS,DEPT PHARM RES & DEV,MONTREAL H3C 3J1,QUEBEC,CANADA
[2] AYERST RES LABS,DEPT CLIN RES,MONTREAL H3C 3J1,QUEBEC,CANADA
关键词
D O I
10.1002/j.1552-4604.1981.tb05652.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:472 / 476
页数:5
相关论文
共 13 条
[1]  
BERGLUND G, 1973, ACTA MED SCAND, V194, P513
[2]   2-PERIOD CHANGE-OVER DESIGN AND ITS USE IN CLINICAL TRIALS [J].
GRIZZLE, JE .
BIOMETRICS, 1965, 21 (02) :467-&
[3]  
GRIZZLE JE, 1974, BIOMETRICS, V30, P727
[4]   DURATION OF ACTION OF BETA-BLOCKERS [J].
JOHANSSON, SR ;
MCCALL, M ;
WILHELMSSON, C ;
VEDIN, JA .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :593-601
[5]  
KORNHAUSER DM, 1978, CLIN PHARMACOL THER, V23, P165
[6]  
KRAML M, 1978, CLIN CHEM, V24, P169
[7]  
LINDQUIST EF, 1956, DESIGN ANAL EXPT PSY, P273
[8]   CONTRIBUTION OF PROPRANOLOL METABOLITES TO FLUOROMETRIC ASSAY OF PROPRANOLOL IN HUMAN-PLASMA [J].
PRITCHARD, JF ;
SCHNECK, DW ;
RACZ, WJ ;
HAYES, AH .
CLINICAL BIOCHEMISTRY, 1978, 11 (03) :121-125
[9]   CLINICAL PHARMACOKINETICS OF PROPRANOLOL [J].
ROUTLEDGE, PA ;
SHAND, DG .
CLINICAL PHARMACOKINETICS, 1979, 4 (02) :73-90
[10]   PROPRANOLOL IN THE CONTROL OF BLOOD-PRESSURE - A DOSE-RESPONSE STUDY [J].
SERLIN, MJ ;
ORME, MLE ;
BABER, NS ;
SIBEON, RG ;
LAWS, E ;
BRECKENRIDGE, A .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 27 (05) :586-592